157 related articles for article (PubMed ID: 26690471)
1. Naringin Reverses Hepatocyte Apoptosis and Oxidative Stress Associated with HIV-1 Nucleotide Reverse Transcriptase Inhibitors-Induced Metabolic Complications.
Adebiyi OO; Adebiyi OA; Owira PM
Nutrients; 2015 Dec; 7(12):10352-68. PubMed ID: 26690471
[TBL] [Abstract][Full Text] [Related]
2. Naringin Ameliorates HIV-1 Nucleoside Reverse Transcriptase Inhibitors- Induced Mitochondrial Toxicity.
Oluwafeyisetan A; Olubunmi A; Peter O
Curr HIV Res; 2016; 14(6):506-516. PubMed ID: 27197616
[TBL] [Abstract][Full Text] [Related]
3. Naringin improves zidovudine- and stavudine-induced skeletal muscle complications in rats.
Adebiyi OO; Adebiyi OA; Owira P
Hum Exp Toxicol; 2017 Jan; 36(1):93-105. PubMed ID: 27005762
[TBL] [Abstract][Full Text] [Related]
4. Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting.
Maisonneuve C; Igoudjil A; Begriche K; Lettéron P; Guimont MC; Bastin J; Laigneau JP; Pessayre D; Fromenty B
Antivir Ther; 2004 Oct; 9(5):801-10. PubMed ID: 15535418
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
[TBL] [Abstract][Full Text] [Related]
6. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
7. High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice.
Igoudjil A; Abbey-Toby A; Begriche K; Grodet A; Chataigner K; Peytavin G; Maachi M; Colin M; Robin MA; Lettéron P; Feldmann G; Pessayre D; Fromenty B
Antivir Ther; 2007; 12(3):389-400. PubMed ID: 17591029
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.
Note R; Maisonneuve C; Lettéron P; Peytavin G; Djouadi F; Igoudjil A; Guimont MC; Biour M; Pessayre D; Fromenty B
Antimicrob Agents Chemother; 2003 Nov; 47(11):3384-92. PubMed ID: 14576092
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs.
Nagiah S; Phulukdaree A; Chuturgoon A
J Cell Biochem; 2015 Sep; 116(9):1939-46. PubMed ID: 25740676
[TBL] [Abstract][Full Text] [Related]
10. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
[TBL] [Abstract][Full Text] [Related]
11. Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction.
Kline ER; Bassit L; Hernandez-Santiago BI; Detorio MA; Liang B; Kleinhenz DJ; Walp ER; Dikalov S; Jones DP; Schinazi RF; Sutliff RL
Cardiovasc Toxicol; 2009 Mar; 9(1):1-12. PubMed ID: 19067249
[TBL] [Abstract][Full Text] [Related]
12. From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.
Curran A; Ribera E
Expert Opin Drug Saf; 2011 May; 10(3):389-406. PubMed ID: 21235431
[TBL] [Abstract][Full Text] [Related]
13. Effect of nucleoside and nucleotide analog reverse transcriptase inhibitors on cell-mediated immune functions.
Enomoto L; Anderson PL; Li S; Edelstein CL; Weinberg A
AIDS Res Hum Retroviruses; 2011 Jan; 27(1):47-55. PubMed ID: 20929390
[TBL] [Abstract][Full Text] [Related]
14. Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.
Nzuza S; Zondi S; Owira PMO
PLoS One; 2017; 12(11):e0183355. PubMed ID: 29121676
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of C-reactive protein and stavudine on adipogenesis.
Stankov MV; Schmidt RE; Behrens GM
Antivir Ther; 2009; 14(6):819-29. PubMed ID: 19812444
[TBL] [Abstract][Full Text] [Related]
16. An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.
Li T; Guo F; Li Y; Zhang C; Han Y; Lye W; He Y; Lu H; Xie J; Huang A; Li Y; Tang X; Wang H; Zhang T; Gao G; Lei J; Zhang X; Wu X; Sun Y; Bai J; Luo L; Wang H
Chin Med J (Engl); 2014; 127(1):59-65. PubMed ID: 24384425
[TBL] [Abstract][Full Text] [Related]
17. First-line therapy and mitochondrial damage: different nucleosides, different findings.
Blanco F; García-Benayas T; José de la Cruz J; González-Lahoz J; Soriano V
HIV Clin Trials; 2003; 4(1):11-9. PubMed ID: 12577192
[TBL] [Abstract][Full Text] [Related]
18. Naringin Mitigates Cardiac Hypertrophy by Reducing Oxidative Stress and Inactivating c-Jun Nuclear Kinase-1 Protein in Type I Diabetes.
Adebiyi AO; Adebiyi OO; Owira PM
J Cardiovasc Pharmacol; 2016 Feb; 67(2):136-44. PubMed ID: 26421421
[TBL] [Abstract][Full Text] [Related]
19. Naringin Reduces Hyperglycemia-Induced Cardiac Fibrosis by Relieving Oxidative Stress.
Adebiyi OA; Adebiyi OO; Owira PM
PLoS One; 2016; 11(3):e0149890. PubMed ID: 26967518
[TBL] [Abstract][Full Text] [Related]
20. New questions about an old combination--ddI + d4T.
Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
